Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
— RRx-001 is a small molecule immunotherapy targeting CD47 – SIRPα that repolarizes tumor associated macrophages — LA JOLLA, Calif.–(BUSINESS…
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of…
TURNHOUT, Belgium & EDMONTON, Alberta–(BUSINESS WIRE)–MindBytes BVBA and its subsidiary, MindLab Interactive AI Inc., (“MindBytes”) today announced that researchers from…
DUBLIN–(BUSINESS WIRE)–The “Label-free Array Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027” report has been…
– BT7480 has been selected as the Company’s lead immuno-oncology candidate to advance into IND-enabling studies CAMBRIDGE, England & BOSTON–(BUSINESS…
Two abstracts and posters highlight the diverse applications of OncoNano’s ultra pH-sensitive micelle technology SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc., a…
Latest release of pharmaceutical treatment experience platform transitions to scalable microservices approach BOSTON–(BUSINESS WIRE)–Human Care Systems, developer of Resilix™, a…
Objective response rate (ORR) of 25% and duration of response of 16.9+ months observed with CMP-001 in combination with pembrolizumab…
SAN DIEGO–(BUSINESS WIRE)–Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today…